Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin H Durham

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Neuro-Oncology|May 16, 2021
Histiocytosis and the nervous system: from diagnosis to targeted therapiesFleur Cohen Aubart, Ahmed Idbaih, Jean-François Emile, et al.
The Journal of Experimental Medicine|July 23, 2017
miR-99 regulates normal and malignant hematopoietic stem cell self-renewalMona Khalaj, Carolien M Woolthuis, Wenhuo Hu, et al.
Blood|August 19, 2016
Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester diseaseEli L Diamond, Omar Abdel-Wahab, Benjamin H Durham, et al.
Blood|November 24, 2021
RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the diseaseSandeep N Wontakal, Mishan Britto, Huan Zhang, et al.
Molecular Cancer Therapeutics|April 25, 2019
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell HistiocytosisFilip Janku, Eli L Diamond, Aaron M Goodman, et al.
Leukemia|June 24, 2023
CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibitionEli L Diamond, Jasmine H Francis, Mario E Lacouture, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 2, 2017
The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohortNeval Ozkaya, Marc K Rosenblum, Benjamin H Durham, et al.
Blood Advances|October 25, 2023
Histiocytic neoplasm subtypes differ in their MAP2K1 mutational typeJean-François Emile, Zofia Hélias-Rodzewicz, Benjamin H Durham, et al.
Pediatric Blood & Cancer|July 28, 2017
Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosisSara Zarnegar, Benjamin H Durham, Pallavi Khattar, et al.
Haematologica|February 24, 2018
Single-agent dabrafenib for <i>BRAF</i><sup>V600E</sup>-mutated histiocytosisAnkush Bhatia, Gary Ulaner, Raajit Rampal, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Neuro-Oncology|May 16, 2021
Histiocytosis and the nervous system: from diagnosis to targeted therapiesFleur Cohen Aubart, Ahmed Idbaih, Jean-François Emile, et al.
The Journal of Experimental Medicine|July 23, 2017
miR-99 regulates normal and malignant hematopoietic stem cell self-renewalMona Khalaj, Carolien M Woolthuis, Wenhuo Hu, et al.
Blood|August 19, 2016
Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester diseaseEli L Diamond, Omar Abdel-Wahab, Benjamin H Durham, et al.
Blood|November 24, 2021
RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the diseaseSandeep N Wontakal, Mishan Britto, Huan Zhang, et al.
Molecular Cancer Therapeutics|April 25, 2019
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell HistiocytosisFilip Janku, Eli L Diamond, Aaron M Goodman, et al.
Leukemia|June 24, 2023
CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibitionEli L Diamond, Jasmine H Francis, Mario E Lacouture, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 2, 2017
The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohortNeval Ozkaya, Marc K Rosenblum, Benjamin H Durham, et al.
Blood Advances|October 25, 2023
Histiocytic neoplasm subtypes differ in their MAP2K1 mutational typeJean-François Emile, Zofia Hélias-Rodzewicz, Benjamin H Durham, et al.
Pediatric Blood & Cancer|July 28, 2017
Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosisSara Zarnegar, Benjamin H Durham, Pallavi Khattar, et al.
Haematologica|February 24, 2018
Single-agent dabrafenib for <i>BRAF</i><sup>V600E</sup>-mutated histiocytosisAnkush Bhatia, Gary Ulaner, Raajit Rampal, et al.
Pageof 7